Format

Send to

Choose Destination
Stem Cell Res. 2019 May;37:101409. doi: 10.1016/j.scr.2019.101409. Epub 2019 Feb 15.

Human induced pluripotent stem cell line HMUi001-A derived from corneal stromal cells.

Author information

1
Eye Hospital, First Affiliated Hospital of Harbin Medical University, Harbin, China; Central Laboratory of Scientific Research, Bashkir State Medical University, Ufa, Russian Federation.
2
Eye Hospital, First Affiliated Hospital of Harbin Medical University, Harbin, China.
3
Department of Pharmacy, the Second Affiliated Hospital of Harbin Medical University (Institute of Clinical Pharmacy, the Heilongjiang Key Laboratory of Drug Research, Harbin Medical University), Harbin, China; Department of Pharmacology (the State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Key Laboratory of Cardiovascular Research, Ministry of Education), College of Pharmacy, Harbin Medical University, Harbin, China.
4
Central Laboratory of Scientific Research, Bashkir State Medical University, Ufa, Russian Federation.
5
Eye Hospital, First Affiliated Hospital of Harbin Medical University, Harbin, China. Electronic address: zelmykqnwyh@163.com.

Abstract

A human corneal stroma induced pluripotent stem cell (HMUi001-A) line was created from primary cultured human corneal fibroblasts. Reprogramming was performed using episomal vector delivery of OCT4, SOX2, KLF4, L-MYC and LIN28. Further characterization of the HMUi001-A confirmed that the cell line was pluripotent, free from Epstein Barr viral genome, and retained normal karyotype.

PMID:
31121475
DOI:
10.1016/j.scr.2019.101409
Free full text

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center